Skip to main navigation
Skip to search
Skip to main content
Fox Chase Cancer Center Home
Help & FAQ
Link opens in a new tab
Search content at Fox Chase Cancer Center
Home
Profiles
Research Units
Research Resources
Research Outputs
Prizes
Activities
Press/Media
Dose response in prostate cancer with 8-12 years' follow-up
Gerald E. Hanks
, Alexandra L. Hanlon
, Barry Epstein
,
Eric M. Horwitz
Cancer Signaling and Microenvironment (CSM)
Radiation Oncology
Fox Chase Cancer Center
Research output
:
Contribution to journal
›
Article
›
peer-review
201
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Dose response in prostate cancer with 8-12 years' follow-up'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Prostate Cancer
100%
Dose Response
100%
Diseases
100%
Prostate Specific Antigen
55%
Distant Metastasis
44%
Malignant Neoplasm
22%
Gleason Score
22%
Median Follow Up
22%
Oncology
11%
Proportional Hazards Model
11%
Morbidity
11%
Cancer Staging
11%
Conformal Radiotherapy
11%
Biochemical Recurrence
11%
Univariate Analysis
11%
Palpation
11%
Radiation Dose Escalation
11%
Radiation Therapy
11%
Multivariate Analysis
11%
Pharmacology, Toxicology and Pharmaceutical Science
Prostate Cancer
100%
Diseases
100%
Prostate Specific Antigen
55%
Distant Metastasis
44%
Fox
22%
Malignant Neoplasm
22%
Gleason Score
22%
Morbidity
11%
Cancer Staging
11%
Biochemical Recurrence
11%
Biochemistry, Genetics and Molecular Biology
Prostate-Specific Antigen
100%
Dose Response
100%
Fox
40%
Gleason Score
40%
Multivariate Analysis
20%
Morbidity
20%
Cancer Staging
20%